Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Prepublished online as a Blood First Edition Paper on October 3, 2002; DOI 10.1182/blood-2002-07-2011.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-07-2011v1
101/5/1713    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Worth, A.
Right arrow Articles by Veys, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Worth, A.
Right arrow Articles by Veys, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted July 17, 2002
Accepted September 20, 2002

Successful treatment of juvenile myelomonocytic leukemia relapsing post stem cell transplant using donor lymphocyte infusion

Austen Worth, Kanchan Rao*, David Webb, Judith Chessells, Jane Passmore, and Paul Veys

Bone Marrow Transplant and Haematology, Great Ormond Street Hospital for Children, London, United Kingdom

* Corresponding author; email: raok{at}gosh.nhs.uk.

Juvenile Myelomonocytic Leukaemia (JMML) is a rare paediatric malignancy. Haematopoietic stem cell transplant (SCT) is the only curative approach. However, relapse post SCT remains the major cause of treatment failure. Unlike most other paediatric malignancies, JMML maybe susceptible to a graft versus leukaemia (GVL) effect although unlike Chronic Myeloid leukaemia, reports of response to donor lymphocyte infusions (DLI) remain scanty. This is the first report that describes the successful treatment of relapsed JMML with DLI in the absence of further chemotherapy and provides definite proof of a GVL effect in JMML.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
N. Hirano, M. O. Butler, Z. Xia, A. Berezovskaya, A. P. Murray, S. Ansen, S. Kojima, and L. M. Nadler
Identification of an immunogenic CD8+ T-cell epitope derived from {gamma}-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia
Blood, October 15, 2006; 108(8): 2662 - 2668.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020